Leeway Marketplace

…Find What You Need, When You Need It

  • RSS
  • Delicious
  • Facebook
  • Twitter
  • Biomedical Sciences
    • Biochemistry
      • Enzymes: Its reactions and Kinetics
      • Carbohydrates: Structures & Functions, Synthesis & Degradation
      • Glycolysis
      • Citric Acid Cycle
      • Glyoxylate Cycle
      • Pentose Phosphate Cycle
      • Lipids: Biosynthesis
      • Insulin and Glucagon: Regulation
      • Steroid Hormones and atherosclerosis
      • Amino acids: Oxidation and Degradation
      • Fatty acids: Oxidation and Formation of Ketone bodies
      • ATP and Bioenergetics: Oxidative Phosphorylation, Electron transport and the effects of Xenobiotics
      • Nucleic acid
      • Protein Synthesis
      • Chromosome: Structure, DNA replication and transcription, effects of antibiotics, Cancer causing viruses
      • Lipids and Membranes
    • Molecular Biology and Genomics
      • Proteins and Lipids: Structures and functions
      • Biochemistry and Cellular Organization
      • Essential Amino acids: Degradations of Purines and Uric acid production
      • Cell signaling (Neurotransmitters, hormones)
      • Cellular growth (The cell cycle)
      • Organization of human genome
        • Gene expression and regulation
      • DNA: Structure and functions
      • Instability of the human genome
        • Replication, Mutation and DNA repair
        • Recombination and developmental genetics
      • Relationships between Genes and Proteins
        • Proteins: Its structures and functions
        • Protein folding and conformation
        • Transcription into RNA
        • mRNA translation into proteins
      • Gene engineering and Cloning of genes
        • Cell-based DNA cloning
        • Cloning vectors
      • Molecular pathology: Identifying human disease genes
        • Its Application: Gene therapy and other molecular gene-based therapeutic approach
    • Human Physiology
      • Respiration
        • How the body obtains oxygen and eliminates carbon dioxide
        • The balance of respiration and PH level in fluids
        • Changes during exercise and various states
      • Kidney
        • How kidney regulate the volume and composition of fluids
        • How the kidney function during malnutrition and various diseases
        • Hormonal regulation
      • Blood and Immune System
        • Cellular and molecular components of the blood: Their roles in oxygen transport
        • Clothing mechanisms and Body’s defense mechanisms
        • Immunology: Dealing with normal immune reactions
      • Cardiovascular system
        • The structure and contractile properties of the heart
        • Mechanical forces regulating blood pressure
        • Hormonal and neural regulating mechanisms
      • Gastrointestinal system
        • Gastric acid secretion
        • How the body obtains nutrients, water and electrolytes
        • Transfer into plasma and various tissues
        • Hormonal and neural regulatory factors in normal and disease states
        • Elimination of undigested food
      • Neurophysiology
        • Description of biological membranes and ionic channels
        • The basis of bioelectricity
        • Detailed explanation of synaptic transmission
          • The synapse as a primary subject of action of various drugs which act upon the nervous system
          • Major sensory systems such as somatosensory, visual and auditory systems
          • The pain perception
          • Neural control of skeletal musculature
          • Mental illnesses
        • Temperature regulation
          • The homeostatic mechanisms regulating body temperature
            • In normal condition
            • During diseases
            • During exercise
        • Endocrinology and Reproduction
          • The hypothalamic system controlling hormonal release
          • The pituitary gland
          • The thyroid gland
          • The adrenal gland
          • The reproductive cycle and its hormonal control
      • Functional Anatomy
        • Introduction to Anatomy
          • The Anatomical position: movement
          • Ultrastructure of the cell
          • Examination of basic tissue type of the body and their functions
        • The Integument
          • Histology of skin
        • Musculoskeletal system
          • Types of muscle: Histology of muscle
          • How movement occurs
          • Regional study – Role of calcium in skeletal contraction
          • Diaphram; Upper limb; Lower limb; and their clinical aspects
        • The Cardiovascular system
          • Mediastinum
          • Arteries Vs Veins: Histological approach
          • Blood as a tissue
          • Heart: Adult Vs Fetal structure and their flow of blood
          • Coronary circulation; conducting system and their clinical aspects
          • Regional Supply
        • The respiratory system
          • Histological survey
          • Pleural and pleural cavity: Breathing movement
          • Clinical aspects
          • Development of respiratory system
        • The Digestive system
          • Anterior abdominal wall
          • Palate and Oral cavity; Salivary glands
          • Esophagus
          • Peritoneal cavity
          • Abdominal viscera
          • Histological aspects and function
          • Clinical anatomy: Small intestine, large intestine, liver, pancreas
          • Blood supply including portal venous system and the “first-pass effect”
        • The Nervous System
          • Introduction to terminology
          • Synaptic morphology; neurotransmission
          • Organization of the nervous system
            • Organization of the nervous system
              • Central Nervous System
                • Spinal Cord: anatomy; meninges; major ascending and descending tracts
                • Brain: gross anatomical features, location and function meninges
                • Cerebral Hemispheres – sulci, gyri, major sensory and motor regions
                • Brain Stem: cerebellum; ventricles
                • CSF: flow, composition, function; blood supply- clinical anatomy
              • Peripheral Nervous System
                • Cranial nerves; spinal nerves; dermatomes; brachial plexus
                • lumbosacral plexus – pudendal and sciatic nerves
              • Autonomic Nervous System
                • Centres of control; sympathetic and parasympathetic systems
                • neurotransmitters
        • Organs of Special Sense
          • Eye, Ear, Olfaction, Taste
        • The Urinary System
          • Function; components and relations
          • Kidneys: location, gross anatomy; histology; flow of urine; ureter, bladder, male and female urethra; pelvic diaphragm
        • The Reproductive System
          • Bony pelvis and perineal region; urogenital triangle; anal triangle; male external genitalia; the breast; the placenta; early embryology; susceptibility of the fetus to critical periods of development
        • The Endocrine System
          • Pituitary gland
          • Thyroid gland
          • Pancreas
          • Parathyroid glands and adrenal glands
        • The Lymphatic System
          • Significance
          • Gross anatomy and histology of lymphatic tissue
          • Lymphatic vessels; lymph node
          • Spleen, thymus, appendix
    • IMMUNOLOGY
      • Overview of the Immune System
        • Specificity and memory
        • Cells and organs of the immune system
        • Clonal selection theory
      • Humoral Immune Responses
        • Antibodies: structure, classes, and function
      • Cell Mediated Immune Responses
        • T cell subsets and functions
        • T cell receptor
        • MHC (Major Histocompatability Complex) molecules
        • Antigen processing and MHC-restricted presentation
        • T cell recognition of antigens
      • Implications to Vaccine Design
        • Conventional and modern vaccines
      • Hybridoma Technology and Monoclonal Antibodies
        • Clinical applications: as research tools and as diagnostic and therapeutic agents
        • Biotechnology and Pharmacogenetics
    • MEDICAL MICROBIOLOGY
      • Introduction to Microbiology
        • Bacterial structure, replication and classification
        • Bacterial pathogenesis and virulence factors
        • Normal microbial flora / Host response to infection
        • Principles of diagnostic microbiology
      • Bacterial Infections
        • Infections of the circulatory system
          • Endocarditis
        • Infections of bones and joints
          • Osteomyelitis, arthritis, prostheses
        • Skin and wound infections
          • Cellulitis, impetigo, wounds
        • Infections of the gastrointestinal tract
          • Food poisoning, gastroenteritis, antibiotic-associated colitis
        • Infections of the eye
          • Conjunctivitis, keratitis
        • Infections of the urogenital tract
          • Urinary tract infections
          • Sexually transmitted infections
        • Infections of the CNS
          • Meningitis
          • Abcesses
        • Infections of the respiratory tract
          • Otitis, pharyngitis, sinusitis
          • Pneumonia, bronchitis, croup
          • Tuberculosis
      • Antimicrobial Agents
        • β-Lactams
        • Quinolones
        • Macrolides, clindamycin, tetracyclines
        • Aminoglycosides, vancomycin
        • Sulfonamides and trimethoprim
        • Metronidazole
      • Viral Infections
        • Properties, structure, replication, and transmission
        • Viral pathogenesis, host response, and principles of diagnostic virology
        • Sites/types of viral infections
          • Respiratory tract
          • CNS
          • Gastrointestinal tract
          • Genitourinary tract
          • HIV and AIDS
          • Hepatitis
          • Measles, mumps, rubella
          • Chickenpox and shingles
          • Infections in the fetus and newborn
        • Antiviral agents
      • Parasitology
        • Protazoal diseases
          • Protazoas and helminths
        • Malaria
        • Ectoparasites
          • Lice, scabies, ticks
      • Mycology
        • Properties, structure, replication, and transmission
        • Systemic mycoses
          • Candidiasis
          • Aspergillosis
          • Histoplasmosis
          • Blastomycosis
          • Coccidiodomycosis
          • Cryptococcosis
        • Superficial mycoses
          • Dermatophytes
        • Antifungal agents
      • Sterilization and Disinfection
        • Infection control methods
      • Immunoprophylaxis and Vaccines
  • 
  • 
  • PHARMACEUTICAL SCIENCES
    • PHARMACEUTICS AND DRUG DELIVERY SYSTEMS
      • The solid state
        • Bonding: Van der Waal’s, hydrogen, covalent, electrostatic, metallic crystal systems and habits
        • Crystallization: saturated and supersaturated solutions, crystal growth
        • Crystallinity: amorphous solids, degree of crystallinity, crystal defects
        • Polymorphism: effects on formulation, bioavailability
        • Hydrates and solvates: hygroscopicity, deliquescence, phase diagrams, effects on formulation, bioavailability, lyophilization
        • Eutectic mixtures, solid solutions, clathrates and inclusion compounds
      • Solid dosage forms
        • Properties of powders, handling of powders, drying, mixing and milling
        • Particle size analysis: definitions, methods
        • Tableting: excipients and formulation, methods of granulation, tablet compression
        • Tablet coating: methods and types of coating
        • Capsules: hard gelatin, soft gelatin, non-gelatin based capsules, formulation
        • Evaluation tests: uniformity of weight, content, dissolution, disintegration, hardness, friability
        • Sustained/controlled release: formulation, effect on bioavailability
        • Effervescent powders and tablets: formulation, storage
      • Solutions and Solubility
        • Thermodynamics of pharmaceutical solutions
        • 1st law, enthalpy, work
        • 2nd law, entropy
        • Gibbs free energy and chemical potential
        • Phase equilibria
      • Pharmaceutical solvents
        • Waters, alcohols, hydroalcohols, cosolvents
      • Aqueous and non-aqueous solutions
        • Syrups, elixirs, tinctures, collodions, spirits, liniments
      • Solvent/solute interacation
        • Intermolecular bonding, functional groups, prediction of drug solubility in water
      • Liquid-liquid solutions
        • Ideal and non- ideal solutions, Raoult’s law, partial miscibility
      • Solid-liquid solutions
        • Colligative properties, solutions of electrolytes and non-electrolytes, ionic equilibria, buffers, isotonicity
      • Gas-liquid solutions
        • Solubility of gases, Henry’s law.
      • Factors affecting solubility
        • pH, pKa, salts, temperature, esterification, complexation, solubilization, particle size, cosolvency, polarity, solubility parameters
      • Dissolution
        • Theory, methods of measuring dissolution rate, factors affecting dissolution rate
        • Hixon-Crowell Cube-Root Relation, Noyes-Whitney equation
        • Types of dissolution apparatuses
        • USP Dissolution monographs and acceptance criteria
        • In vitro – in vivo correlation
      • Partition
        • Fick’s first and second laws, Nernst distribution law, pH-partition theory,steady state and non-steady state diffusion
      • Surface Chemistry and Dispersed Dosage Forms
        • Interfacial tension, spreading, contact angle, tendency of wetting
        • Nature & properties of surfaces, interfaces-absorption at liquid & solid interfaces
        • Surfactants: classification, properties, pharmaceutical applications (HLB, wetting, solubilization, detergency)
      • Emulsions
        • Emulsion types, applications, emulsifying agents
        • Physical stability: creaming, coalescence, cracking, inversion
        • Formulation, preservation
        • Microemulsions: formulation, physicochemical properties, applications
      • Suspensions
        • Desired characteristics, applications
        • Electrical properties, Zeta potential, Nernst potential
        • Physical stability: flocculation, deflocculation, sedimentation
        • Formulation
        • Rheological properties of vehicles including hydrocolloids, thixotropy, rheopexy,structured vehicles
      • Drug Stability
        • Drug stability
          • Physical, chemical, microbiological stability: definitions, causes of instability
        • Chemical stability
          • Mechanisms of degradation: hydrolysis, oxidation, photolysis
          • Zero and first order degradation: rate equations, half-life, shelf-life
          • Effect of temperature, ionic strength, solvents and pH on reaction kinetics
          • Factors affecting rates of hydrolysis and oxidation, stability programs, stabilitytesting, accelerated stability studies
          • Stabilization of drugs against hydrolysis, oxidation and photolysis
      • Pulmonary Drug Delivery
        • Components of aerosols: propellants, valves, containers
        • Formulation of aerosols: solutions, suspensions, emulsions
        • Design of aerosols: metered dose inhalers, dry powder inhalers, nebulizers, spacer devices
        • Inhalation therapy: deposition of particles in the lungs, metered dose inhalers, powderinhalers, nebulizers
      • Dermal and Transdermal Drug Delivery
        • Skin structure: nature of barrier to percutaneous absorption
        • Percutaneous absorption: diffusion, partitioning, flux
        • Factors affecting percutaneous absorption: skin intactness, age, site, hydration, partitioncoefficient, solubility, penetration enhancers and formulation
        • Types of dermatological vehicles: ointments, creams, gels, liquids, pastes, selection ofappropriate vehicle in topical drug therapy
      • Parenteral Drug Delivery
        • Methods of sterilization, sterility testing, pyrogen testing, tests for particulate matter
        • Routes of administration: advantages, disadvantages
        • Formulation: vehicles, additives, osmolarity, osmolality, particle size
        • Principles of aseptic technique, reconstitution, intravenous admixtures and causes ofincompatibilities
        • Total parenteral nutrition: design of solution, preparation, administration, complications
      • Ophthalmic, Otic, Nasal Drug Delivery
        • Ophthalmic drug delivery
          • Cornea as a barrier to drug absorption
          • Formulation: tonicity, sterility, pH additives
        • Otic drug delivery
          • Site of drug administration
          • Formulation
        • Nasal drug delivery
          • Formulation: pH, additives
        • Rectal and Vaginal Drug Delivery
          • Definition and uses
          • Preparation, excipients, density displacement factors
          • Stability
        • Vaginal tablets, ointments, creams, gels and aerosol foams
      • New Drug Delivery Systems
        • Controlled/targeted delivery
          • Controlled drug release, targeted drug delivery: definitions, rationale, comparison to conventional delivery systems
          • Parenteral polymeric delivery systems: biodegradable, non-degradable, polymers, reservoirs, matrices, mechanisms of drug release, formulation of implants, microspheres, nanospheres
          • Liposomes: formulation, interaction with cells, applications, targeting
          • Transdermal drug delivery: applications, mechanisms of controlled release formulations
          • Immunoconjugates and new innovations
        • Protein drug delivery
          • Protein drug delivery: formulation strategies to stabilize proteins, formulation of protein/peptide drugs using conventional injections, formulation of polymer implants or microspheres
          • Nasal and pulmonary delivery: physiology, use of penetration enhancers
          • Buccal delivery and other potential delivery systems
        • Good Manufacturing Practices (GMP)
        • Batch record
        • International Organization for Standardization (ISO)
        • Lot number
      • Product Quality Control and Risk Management
      • Places
        • Premises and equipment
      • People
        • Personnel and quality assurance
      • Processes
        • Sanitation program and operations
      • Products
        • Specifications, stability, samples, batch records, recall reporting, sterile products
      • Pharmaceutical Analysis
        • Chromatographic separation methods
          • High Pressure Liquid Chromatography (HPLC)
          • Gas Liquid Chromatography (GLC)
        • Other chromatographic detectors
          • Fluorescence
          • Radiometric assays (gamma and beta counting)
        • Spectrophotometry and other analytical methods
          • Ultraviolet-visible
          • Infrared and Nuclear Magnetic Resonance (NMR) spectrometry
          • Atomic absorption
          • Mass spectrometry
          • Gel electrophoresis and Western blot
    • PHARMACOKINETICS & BIOPHARMACEUTICS
      • Compartment Concepts
        • One compartment open model
        • Multicompartmental models
        • Model-independent pharmacokinetics
      • Absorption
        • Kinetics of oral drugs (absorption and elimination)
        • Kinetics after one dose
        • Kinetics after multiple doses
        • Zero-order absorption model
        • First-order absorption model
        • Significance of absorption rate constant
        • Physiologic factors related to oral absorption
        • Modified release of drug products
      • Distribution and Protein Binding
        • Physiologic factors
        • Volume of distribution
        • Kinetics of protein binding
      • Elimination and Clearance Concepts
        • Drug clearance
        • Renal clearance
        • Hepatic clearance
        • Biotransformation
      • Kinetics of Intravenous (IV) Drugs
        • IV Bolus
        • IV infusion
        • IV intermittent infusion
        • Multiple daily dosage regimens
      • Kinetics of Doses
        • After constant input
        • After 1st order input
      • Model-Independent Pharmacokinetics
        • Nonlinear pharmacokinetics
      • Bioavailability and Bioequivalence Issues
      • Clinical Application of Pharmacokinetics
        • Dosage regimens
        • Effects of pathophysiologic changes: monitoring and adjustment of doses in renal and hepatic dysfunction
        • Kinetics of drug interactions
        • Special populations
          • Pediatric patients
          • Pregnant and lactating women
          • Geriatric patients
        • Therapeutic drug monitoring
          • Drugs in renal failure: Aminoglycosides, cyclosporine
          • Drugs with saturable kinetics: Phenytoin
          • Drugs with linear kinetics: Digoxin
      • Examples of Pharmacokinetics Calculations
        • Pharmacokinetic rate constants
          • Apparent volume of distribution, elimination rate constant, half-life, clearance
        • Blood drug concentration following IV bolus dose administration
          • One compartment model
          • Two compartment model
        • Drug concentration vs. time curves
          • Determining what model the drug follows
        • Clearance rates
        • Loading doses and time to reach steady state
        • Pharmacokinetic-pharmacodynamic modeling
    • MEDICINAL CHEMISTRY
      • Fundamental Aspects of Organic Chemistry
        • Chemical bonding: introductory aspects, such as atomic orbitals, molecular orbitals, localized versus delocalized chemical bonding, specific bond types (e.g.,covalent and ionic), aromaticity, and tautomerism.
        • Stereochemistry
        • Solubility
        • Acidity and basicity
        • Functional groups
          • Aliphatic and aromatic hydrocarbons
          • Alcohols and phenols
          • Ethers
          • Aldehydes and ketones
          • Amines
          • Carboxylic acids
          • Functional derivatives of carboxylic acids
          • Sulfonic acids and sulfonamides
          • Heterocycles
          • Nitrates and nitrites
      • Fundamental Concepts of Medicinal Chemistry:
        • Structure-activity relationships
        • Ionization and pKavalues: electronic effects in medicinal compounds
        • Metabolism: routes of metabolism, specific isozymes, induction and inhibition ofenzymes giving rise to specific drug interactions, and genetic polymorphism ofclinical relevance.
        • Transporters
        • Chemical and physical properties of related medicinal compounds
      • Drug/Receptor Interactions: Theory and Practice
        • Drug-receptor binding: importance of the equilibrium dissociation constant
        • Fraction of bound receptors and the analogous enzyme-substrate relationships
        • Importance of hydrophilic and hydrophobic interactions
    • PHARMACOLOGY
      • General Principles of Pharmacology
        • Drug absorption, disposition, biotransformation, elimination
      • Receptors
        • Receptor theory, macromolecular structure of receptors, signal transductionmechanisms, molecular pharmacology
        • Drug/receptor interactions
          • Evidence of specific receptor-mediated processes
          • Agonists/antagonists
          • Dose-response curves
          • Desensitization and super-sensitivity
      • Autonomic Pharmacology
        • Drugs and catecholamine metabolism
        • Sympathomimetics (adrenergic agents)
        • Sympatholytics (adrenergic blocking agents)
        • Cholinergic drugs
        • Anticholinesterases
        • Anticholinergics
        • Skeletal muscle relaxants
      • Anaesthetics
        • Local anaesthetics
        • General anaesthetics
      • Pharmacology of Inflammation
        • Chemical mediators of inflammation
          • Histamine, prostaglandins, leukotrienes, bradykinin, platelet activating factor,cytokines
        • Anti-inflammatory drugs
          • ASA, NSAIDs, COX-2 inhibitors, 5-ASA
        • Immunosuppressive drugs
        • Drugs used in the treatment of inflammatory diseases
          • Asthma
          • Rheumatoid arthritis
          • Gout
        • Biologic response modifiers
      • Central Nervous System Pharmacology
        • Pain and opioid analgesics
        • Anxiolytic drugs
        • Sedative/hypnotic drugs
        • Antipsychotics
        • Antidepressants
        • Psychostimulants
        • Anti-Parkinson drugs
        • Antiseizure drugs
        • Drugsfor Alzheimer’s disease
        • Drugs for migraine
      • Drugs Affecting the Haematopoietic System
        • Iron, folic acid, vitamin B12 , erythropoietin, filgrastim
      • Cardiovascular Pharmacology
        • Antiarrhythmic drugs
        • Cardiac glycosides and inotropic drugs
        • Vasodilators
        • Calcium channel blockers
        • Beta-blockers
        • ACE inhibitors
        • Angiotensin receptor antagonists
        • Nitrates
        • Antihypertensive agents
      • Hemostasis and Thrombosis
      • Vitamin K
      • Oral anticoagulants
      • Heparins (including low molecular weight heparins)
      • Anti-Xa inhibitors
      • Direct thrombin inhibitors
      • Thrombolytics
      • Drugs for Dyslipidemia
      • Diuretics
      • Cancer Chemotherapy
        • Alkylating agents, antimetabolites, cytotoxic antibiotics, plant alkaloids, hormones,biologic response modifiers
        • Adjunctive agents including antiemetics
      • Gastrointestinal Pharmacology
        • Drugs affecting GI motility
        • Drugs affecting gastric secretion
        • Anti-obesity drugs
      • Endocrine Pharmacology
        • Insulin and oral antihyperglycemics
        • Corticosteroids
        • Thyroid and anti-thyroid drugs
        • Androgens and anabolic steroids
        • Estrogens and anti-estrogens, progestins, hormonal contraception (oral and otherroutes)
        • Gonadotropins
        • Vasopressin
        • Oxytocin
        • Bone mineral homeostasis
      • Anti-Infective Agents
        • Antibacterial drugs
        • Beta-lactam antibiotics, carbapenems, sulphonamides, trimethoprim,tetracyclines, aminoglycosides, macrolides, fluoroquinolones, vancomycin,metronidazole, nitrofurantoin.
        • Antiviral drugs
        • Antifungal drugs
        • Antiprotozoal drugs
        • Anthelmintic drugs
      • Respiratory Drugs
        • Antitussives
        • Anti-inflammatory agents
        • Bronchodilators
      • Ophthalmic Drugs
        • Antiglaucoma agents
        • Mydriatics
      • Drugs of Abuse
        • Ethanol, amphetamines, barbiturates, benzodiazepines, nicotine, cannabis, GHB,cocaine/crack, fentanyl, heroin, ketamine, methadone, nitrites, solvents, hallucinogens, cocaine/crack, fentanyl, heroin, ketamine, methadone, nitrites, solvents, hallucinogens.
    • TOXICOLOGY AND CLINICAL TOXICOLOGY
      • Introduction to Toxicology
        • Perspective: subdisciplines, magnitude, monitoring, resources
        • Pharmacological principles: relation of toxic response to frequency, dose and tissueconcentration
        • Discrimination among toxins
      • Mechanisms
        • Receptor-mediated vs. reactive intermediate-mediated toxicity
        • Covalent binding, oxidative stress
        • Elimination, bioactivation, detoxification, cytoprotection and macromolecular repair
      • Modulators of Chemical Toxicity
        • Pharmacological factors
          • Disposition, biotransformation, renal elimination
        • Physiological factors
          • Species, strain, age, sex, genetics, diet, pregnancy, functional reserve capacity,tolerance
        • Pathophysiological factors
          • Diseases of hepatic, renal cardiovascular, pulmonary, gastrointestinal andbiochemical systems
      • Toxicological Evaluation
        • Chemical measurements
          • Biological relevance of measuring active and inactive parent chemical andmetabolites, stereoisomers and reactive intermediary metabolites
          • Biochemical measurements of cellular response
          • Biochemical measurements of cellular response, in vivo andin vitrostudies,exvivohuman assessment
      • Chemical Teratogenesis
      • Carcinogenesis/Mutagenesis
      • Chemicals and Environmental Toxins
        • Alcohols, glycols, aldehydes, nitrates and nitrites, sulfide, hydrocarbons
        • Carbon monoxide, cyanide
        • Pesticides
        • Metals
        • Corrosives
        • Plants
        • Warfare chemical weapons
      • Drug Toxicity
        • Analgesics and anti-inflammatory drugs
        • Opioids
        • CNS stimulants and depressants, antidepressants, hallucinogens
        • Anticholinergics
        • Cardiovascular drugs
        • Vitamins
    • BIOTECHNOLOGY AND PHARMACOGENETICS
      • Introduction to Biotechnology
        • Modern biotechnology and its impact on development of drugs and pharmacy practice
        • Pharmacoeconomics of biotechnology drugs
      • Recombinant DNA Technology and Production of Protein Drugs
        • Review of protein biosynthesis in prokaryotic and eukaryotic cells
        • Regulation of gene expression
        • Methods of creating recombinant DNA
        • Isolation of cloned genes
          • cDNA cloning, genomic DNA cloning
        • Expression of recombinant proteins
          • Host cells, expression vectors
          • Strategies in design of recombinant plasmids for pharmaceuticals (e.g., humangrowth hormone)
      • Industrial Production of Protein Drugs
        • Modern fermentation technology
        • Requirements for bacterial, yeast and mammalian cell culture
        • Overview of fermenter design and fermentation processes
        • Large-scale production of protein pharmaceuticals with examples
        • Production of biotechnology drugs
          • Cultivation and downstream processing
          • Issues to consider in production and purification of proteins
          • Formulation of biotechnology drugs
            • Sterility, pyrogen removal
            • Excipients used in biotechnology drugs (parenteral formulations)
            • Shelf-life of biotechnology drugs
            • Delivery of biotechnology drugs: route of administration and absorptionenhancement; rate-controlled delivery; site-specific delivery enhancement; rate-controlled delivery; site-specific delivery
          • Pharmacist’s role with biotechnology products
            • Dispensing biotechnology drugs: handling and special considerations; storage;preparation; administration; patient assessment and monitoring; outpatient/homecare issues.
            • Pharmacotherapeutics of approved biotechnology products (clinical and regulatoryaspects)
              • Hematopoietic growth factors
              • Interleukins and interferons
              • Insulin
              • Growth hormones
              • Recombinant tissue-type plasminogen activator
              • Gonadotropins
              • Monoclonal antibody-based pharmaceuticals
      • Biotechnology-related Techniques
        • Polymerase chain reaction
        • DNA sequencing
        • DNA hybridization
        • Protein engineering
          • Site-directed mutagenesis
          • Antibody engineering
        • Peptide chemistry/medicinal chemistry
          • Peptidomimetic drugs
          • Rational design of peptide drugs
        • Nucleic acid technologies
          • Antisense oligonucleotides
          • DNA triplex technology
          • Ribozymes
        • Catalytic antibodies (abzymes)
        • In vitroscreening and combinatorial chemistry
      • Transgenic (TG) Animals
        • Production of TG animals by DNA injection (gain-of-function)
        • Production of TG animals by homologous recombination (loss-of-function)
        • Protein production in TG animals
        • TG animal models of disease and application in drug discovery and development
        • TG animal patents
      • Gene Therapy
        • Approaches and targeted diseases
        • Methods forex vivoandin vivodelivery of genes to somatic cells
        • Applications to diseases
          • ADA deficiency, cystic fibrosis, and cancer
        • Case studies of current clinical trials
        • Potential diseases where gene therapy could be applied to or is currently used fortreatment
        • Gene transfer methods
          • Viral vectors (retrovirus vectors, adenovirus vectors, etc.)
      • Pharmacogenomics and genotyped prescribing (future role for pharmacists)
      • Antisense Oligonucleotide Therapy
        • Inhibition of gene expression by oligonucleotides
        • Design of oligonucleotides and approaches to delivery
      • Small interfering RNA (siRNA)
        • Mechanism, potential applications
      • Immunology: Overview of the Immune System
        • Specificity and memory
        • Cells and organs of the immune system
        • Clonal selection theory
        • Humoral immune responses
          • Antibodies: structure, classes, and function
        • Cell mediated immune responses
          • T cell subsets and functions
          • T cell receptor
          • MHC molecules
          • Antigen processing and MHC-restricted presentation
          • T cell recognition of antigens
          • Implications to vaccine design
      • Monoclonal Antibodies
        • Hybridoma technology
        • Applications: as research tools, and as diagnostic and therapeutic agents
      • Vaccines: Biotechnology Approaches
        • Cloned proteins: Hepatitis B
        • Synthetic peptides: AIDS
        • Synthetic carbohydrates: Cancer
        • Attenuated organism with site-specific mutation: Cholera
        • Vaccine delivery systems
          • Live vectors
          • Pharmaceutical formulations
      • Cytokines
        • General characteristics, classification
        • Origin, molecular characteristics and physiological function of each cytokine
        • Therapeutic cytokines
          • Interferons, interleukins and colony stimulating factors
      • Erythropoietin
      • Thrombolytic Agents
      • Formulation of Protein and Peptide Drugs
        • Problems: stability, bioavailability and routes of administration
        • Recent approaches in protein and peptide drug delivery
  • 
  • 
  • PHARMACY PRACTICE– Clinical Sciences
    • PATHOPHYSIOLOGY
      • Cell Injury and Death
        • Mechanisms of cell injury
          • Ischemia/hypoxia
          • Free radicals
          • Chemical injury
        • Laboratory investigation
          • Morphology – reversible injury, necrosis, apoptosis
          • Biochemical changes
      • Genetics
        • Common chromosomal syndromes
        • Pharmacogenetics
      • Fluid and Electrolyte Disorders
        • Metabolic acid-base disorders
        • Disorders of oxygenation
      • Inflammation
        • Acute inflammation
        • Chronic inflammation
          • Inflammatory events and mediators
        • Edema
      • Immunopathology
        • Hypersensitivity reactions
          • Four major types: immediate (anaphylactic), cytotoxic, immune complex, delayed
        • Autoimmune diseases
      • Obstructive Lung Disease
        • Asthma
        • Chronic obstructive pulmonary disease (COPD)
      • Gastrointestinal Disease
        • Gastroesophageal reflux disease (GERD)
        • Peptic ulcer disease
        • Inflammatory bowel disease
          • Crohn disease
          • Ulcerative colitis
        • Zollinger-Ellison syndrome
      • Liver Disease
        • Cholestasis
        • Hepatitis (A, B, C)
        • Cirrhosis
        • Drug-induced hepatotoxicity
      • Renal Disease
        • Acute renal insufficiency
        • Chronic renal insufficiency
      • Endocrine Disorders
        • Thyroid disorders
          • Hyperthyroidism
          • Hypothyroidism
        • Adrenal disorders
          • Cushing’s Syndrome
          • Addison’s Disease
        • Metabolic bone disorders
          • Osteoporosis
          • Osteomalacia
          • Paget’s Disease
        • Glucose metabolism and disorders
          • Diabetes mellitus (type 1 and type 2)
        • Cardiovascular
          • Dyslipidemia
          • Ischemic heart disease
          • Myocardial Infarction
          • Hypertension
          • Heart failure
          • Dysrhythmias
          • Coagulation and thrombotic disorders
        • Haematology
          • Anemias
            • Normocytic (i.e., thalassemias, sickle cell anemia)
            • Microcytic (i.e., iron deficiency anemia)
            • Macrocytic (i.e., vitamin B12 deficiency and folic acid deficiency)
          • Haemostatic disorders
        • Neurology
          • Neurodegenerative diseases
            • Alzheimer’s disease and dementias
            • Parkinson’s Disease
          • Pain and headache
            • Acute or chronic
            • Migraine
          • Seizure disorders
          • Stroke
        • Psychiatry
          • Anorexia, bulimia, and eating disorders
          • Anxiety
          • Attention deficit hyperactivity disorder (ADHD)
          • Bipolar disorder
          • Depression
          • Insomnia
          • Schizophrenia
        • Carcinogenesis and Neoplasia
          • Sites
            • Lung neoplasms
            • Gastrointestinal neoplasms
            • Gynecologic neoplasms
            • Urinary tract neoplasms
            • Hematology (e.g., leukemia and lymphoma)
            • Skin neoplasms (e.g., malignant melanoma and others)
            • Cancer of the bone, brain, breast, prostate
    • CLINICAL BIOCHEMISTRY / LABORATORY AND DIAGNOSTIC TESTING
      • Routine Hematology
        • Hematocrit and hemoglobin
        • Red blood cell count
        • Red cell indices (MCV, MCH, MCHC)
        • Complete blood count (CBC)
        • WBC differential (components)
        • Platelets
      • Hematologic Diagnostic Tests
        • Anemias (iron, ferritin, TIBC)
        • Coagulation tests (INR, aPTT)
      • Electrolytes and Blood Chemistry
        • Sodium
        • Potassium
        • Chloride
        • Glucose (random or FBG)
        • Uric Acid
        • Arterial blood gases (PaO2, PaCO2)
        • pH
        • Anion gap
        • Bicarbonate
      • Liver Biochemistry
        • Bilirubin
        • Alkaline phosphatase (ALP)
        • Transaminases (AST, ALT)
        • Albumin
        • α-Fetoprotein
      • Bone Metabolism
        • Bone mineral density
        • Minerals (calcium, phosphate)
        • Magnesium
        • Vitamin D
      • Renal Function and Disorders
        • Urinalysis
        • Urine electrolytes
        • Blood urea nitrogen (BUN)
        • Serum creatinine
      • Estimation of Glomerular Filtration Rate (GFR) and Renal Blood Flow
        • Methods of calculation and use of nomograms
        • Creatinine clearance
      • Gastrointestinal Tract
        • Schilling’s test
        • Occult blood
        • Endoscopy
      • Pulmonary Function Tests
        • Pulmonary function testing
        • Histamine, methacholine challenge test
      • Neurology
        • Cerebral spinal fluid (CSF)
      • Cardiovascular Diagnostic Tests
        • Cardiac isoenzymes (including creatine kinase)
        • Troponin
        • Lipoprotein profile (LDL, HDL, triglycerides, total cholesterol)
      • Neoplasm Screening
        • Prostate-specific antigen (PSA)
        • Breast self-examination
        • Mammogram
        • Pap smear
      • Endocrinology
        • Hypothalamus-pituitary axis
          • Prolactin
          • Growth hormone (GH)
          • Gonadotropins (LH and FSH)
          • Adrenocorticotropin (ACTH)
        • Adrenal disorders
          • Plasma cortisol
          • Urine and serum osmolality
        • Thyroid function
          • TSH
          • Free T3
          • Free T4
        • Sex hormones
          • Pregnancy testing
        • Diabetes and glucose monitoring
          • Glucose tolerance test
          • Fasting blood glucose
          • Urine ketones
          • Glycosylated hemoglobin (A1C)
        • Infectious Disease / Immunologic / Rheumatologic /Other Tests
          • HIV tests
          • Western blot
          • CD4+ T-cell counts
          • Erythrocyte sedimentation rate
        • Laboratory Aspects of Antimicrobial Agents
          • Culture and sensitivity tests
    • PHARMACOTHERAPEUTICS (INCLUDING PRESCRIPTION, NONPRESCRIPTION ANDCOMPLEMENTARY THERAPY)
      • Respiratory Diseases
        • Asthma
        • Chronic obstructive pulmonary disease (COPD)
        • Croup
        • Smoking cessation
      • Dermatology
        • Acne
        • Acne rosacea
        • Allergic contact dermatitis
        • Atopic dermatitis
        • Burns
        • Cellulitis
        • Dermatomycosis
        • Diaper rash
        • Dry skin
        • Impetigo
        • Pediculosis and scabies
        • Onychomycosis
        • Sunburn and photosensitivity reactions
        • Viral infections (including chicken pox, herpes and shingles)
      • Eye, Ear, Nose and Throat
        • Acute otitis media
        • Allergic rhinitis
        • Bacterial conjunctivitis
        • Bacterial sinusitis
        • Glaucoma
        • Mucositis
        • Otitis externa
        • Pharyngitis
        • Teething
        • Viral upper respiratory tract infections
      • Gastroenterology
        • Cirrhosis
        • Constipation
        • Diarrhea
        • Dyspepsia and peptic ulcer disease
        • Esophagitis
        • Gastroesophageal reflux disease (GERD)
        • Gastrointestinal bleeding
        • Hepatotoxicity and liver dysfunction
        • Infant feeding problems including colic
        • Inflammatory bowel disease: including Crohn disease and ulcerative colitis
        • Irritable bowel syndrome
        • Nausea and vomiting
        • Pseudomembranous colitis
      • Cardiovascular diseases
        • Angina
        • Cardiac insufficiency (including heart failure)
        • Cerebrovascular accident (including ischemic stroke)
        • Venous thromboembolism (DVT and PE)
        • Dyslipidemia
        • Endocarditis prophylaxis
        • Hypertension
        • Myocardial infarction
        • Rhythm disorders
      • Genitourinary diseases
        • Benign prostate hypertrophy
        • Prostate cancer
        • Urinary incontinence
        • Urinary tract infections (cystitis, pyelonephritis, and prostatitis)
      • Musculoskeletal diseases
        • Chronic pain
        • Multiple sclerosis
        • Osteoarthritis
        • Osteoporosis
        • Rheumatoid arthritis
        • Skeletal pain
        • Post-operative pain
        • Tendonitis and sport injuries
      • Gynecology
        • Bacterial vaginitis
        • Contraception (including emergency contraception)
        • Endometriosis
        • Erectile dysfunction
        • Fertility
        • Menopause
        • Pregnancy
        • Premenstrual syndrome (PMS)
        • Vaginal candidiasis
      • Infectious Diseases
        • Bone and joint infections (osteomyelitis)
        • Central nervous system infections (meningitis)
        • Infections related to travel
        • Endocarditis
        • Fungal infections
        • Gastrointestinal infections (includingC. difficile-associated diarrhea
        • HIV and AIDS (including opportunistic infections)
        • Intra-abdominal infections
        • Malaria
        • Pneumonia (community acquired pneumonia and nosocomial)
        • Respiratory tract infections (lower and upper)
        • Sepsis and septic shock
        • Sexually transmitted infections
        • Skin and soft tissue infections
        • Surgical prophylaxis
        • Tuberculosis
        • Urinary tract infections (UTIs)
      • Neurology
        • Alzheimer’s disease and other dementias
        • Headaches (migraine, tension-type, cluster, medication overuse)
        • Neuropathic pain
        • Parkinson’s disease
        • Seizure disorders (including partial, generalized, status epilepticus and others)
      • Endocrinology
        • Breast cancer
        • Diabetes mellitus (types 1 and 2)
        • Hypothyroidism
        • Hyperthyroidism
      • Psychiatry
        • Aggressive behaviour
        • Anxiety disorders
        • Bipolar disorder
        • Depression
        • Drug withdrawal syndromes
        • Insomnia and sleep disorders
        • Obsessive-compulsive disorder
        • Panic disorder
        • Personality disorders
        • Schizophrenia
      • Nephrology
        • Chronic renal dysfunction
        • Nephrotoxicity
        • Renal transplantation
      • Other
        • Anemias
        • Chemotherapy and related toxicities
        • Dehydration
        • Fluid and electrolyte disorders
        • Obesity
    • HEALTH PROMOTION AND DISEASE PREVENTION
      • Development of health promotion strategies
        • Health and wellness of individuals and groups
        • Collaboration with other health care providers
      • Public Health Agency of Canada
        • Travel health
        • Vaccies and immunizations
        • Disease prevention
      • Preventative health services (e.g., immunizations, tobacco cessation counselling)
    • PATIENT CARE PROCESS
      • Assessment
        • Meet the patient and establish the therapeutic relationship
        • Elicit relevant information from the patient
        • Determine whether the patient’s drug-related needs are being met and identify drugtherapy problems:
          • The patient requires drug therapy but is not receiving it,
          • The patient is taking or receiving the wrong drug,
          • The patient is taking or receiving too little of the right drug,
          • The patient is taking or receiving too much of the right drug,
          • The patient is not taking or receiving the drug or is taking or receiving the druginappropriately,
          • The patient is experiencing an adverse reaction to the drug,
          • The patient is experiencing a drug interaction (including drug-drug, drug-food, drug-laboratory test, drug-disease, or drug-blood product),
          • The patient is taking or receiving a drug for no medically valid indication or substanceabuse.
      • Care plan
        • Establish goals of therapy
        • Select appropriate interventions for:
          • Resolution of drug therapy problems
          • Achievement of goals of therapy
          • Prevention of drug therapy problems
        • Schedule a follow-up evaluation
      • Follow-up evaluation
        • Elicit clinical and/or lab evidence of actual patient outcomes and compare them to thegoals of therapy to determine the effectiveness of drug therapy
        • Elicit clinical and/or lab evidence of adverse effects to determine the safety of therapy
        • Assess patient for any new drug therapy problems
        • Schedule the next follow-up evaluation
      • Documentation
        • Document clinical status and any changes in pharmacotherapy that are required
        • Application of privacy legislation and ethical considerations
        • Preparation and maintenance of patient records (includes profiles, charts, etc)
    • SPECIAL POPULATIONS
      • Unique pharmacotherapeutic considerations for special populations including:
        • Neonates
        • Pediatrics
        • Geriatrics
        • Pregnant women
        • Lactating women
    • NUTRITION
      • Digestion
      • Function of nutrients in the body
      • Dietary requirementsand Food Guide
      • Assessment of nutritional status
      • Malnutrition and effects on health
      • Metabolism and transport of nutrients
      • Regulation of blood glucose
      • Weight management and eating disorders
  • 
  • 
  • PHARMACY PRACTICE – Professional Practice Skills
    • PRESCRIPTION PROCESSING AND PRODUCTPREPARATION
      • Accurate interpretation of prescription orders
      • Application of legislative requirements (federal legislation only) – see Law/Jurisprudencesection also
      • Non-sterile and sterile compounding
      • Handling of hazardous drugs
      • Cold chain management
      • Checking processes for dispensing prescriptions, including:
        • Appropriateness of medication choice
        • Therapeutic duplication
        • Correct dosage, route, dosage form, frequency, and duration of therapy
        • Allergies and contraindications
        • Drug interactions
        • Adherence issues
        • Financial considerations (pricing, third party billing, quantity restrictions, etc)
    • PRESCRIPTION CALCULATIONS
      • Systems and units of measure (including metric system, SI)
        • Intersystem conversion
      • Dosage calculations
        • Amount of drug
        • Number of doses
        • Dosing based on body weight, body surface area
        • Dosing based on age or pharmacokinetic parameters
      • Compounding calculations (non-sterile and sterile)
        • Ratio and proportion
        • Percentage
        • Dilution and concentration
        • Stock solutions
        • Alligation
        • Electrolyte solutions (milliequivalents, millimoles, osmolarity)
      • Dosing calculations for parenteral medications
        • Reconstitution
        • Infusion flow rate
        • Total parenteral nutrition (TPN)
      • Prescription processing calculations
        • Dispensing fees
        • Insurance co-payments
    • COMMUNICATION / PATIENT COUNSELLING
      • Pharmacist interactions in the workplace
        • Effective dialogue with patients, caregivers, and other health providers
        • Individual consultations
        • Presentations to a group
        • Staff relations
      • Development of effective communication skills
        • Dialogue and interviewing techniques/process
        • Verbal and nonverbal listening
        • Probing and gathering information
        • Empathy, assertive skills
        • Cultural diversity and other patient variables
      • Patient counselling and education on prescription medications, including:
        • Pulmonary delivery
        • Ophthalmic, otic, and nasal delivery
        • Topical products
        • Vaginal and rectal delivery
        • Transdermal delivery
        • Oral, sublingual, and buccal dosage forms
        • Parenteral products
        • Other
      • Patient counselling and education to promote adherence to regimens and therapy
        • Strategies to optimize adherence
        • Identification of under-utilization of medication
        • Identification of over-utilization of medication
      • Patient counselling and education on diagnostic/monitoring tools, including:
        • Home blood glucose monitoring
        • Blood pressure monitors
        • Home pregnancy/ovulation test kits
        • Thermometers
        • Peak flow meters
      • Patient counselling and education on nonprescription medications
        • Self-care topics and issues
      • Patient counselling and education on “no public access” medications
      • Patient counselling and education on herbal and complementary therapies
      • Patient counselling and education on home health care, including:
        • Medical supplies
        • Aids for daily living
        • Foot care
        • Wound care
        • Other
    • DRUG INFORMATION
      • Selection of suitable references and information databases
        • Cochrane Collaborative Library
        • Medline
        • Micromedex
        • Lexicomp
        • RxFiles
        • RxTx
        • Primary, secondary, tertiary references
      • Response to drug information requests
    • LITERATURE EVALUATION / RESEARCH METHODS /EVIDENCE-BASED DECISION-MAKING(including PHARMACOEPIDEMIOLOGY)
      • Evaluation of drug literature and scientific information (critical appraisal)
        • Clinical Trials
        • Evidence-based medicine
        • Clinical practice guidelines
        • Systematic reviews and meta-analysis
        • Observational studies
        • Conflict of interest, publication bias, research funding source, researchethics, institutional review boards (IRB)
        • Cochrane Collaboration and similar agencies
      • Research Methods
        • Design
        • Placebo-controlled, cross-over, washout, factorial, N of 1, parallel
        • Randomized, cohort, case-control, cross sectional, case reports,population studies
        • Experimental, causal-comparative, correlational, descriptive, historical
      • Measures
        • Frequency
          • Prevalence, incidence, cumulative incidence, risk
        • Association
          • Relative risk reduction or benefit, absolute risk reduction orbenefit, odds ratio, number-needed-to-treat, hazards ratio
        • Validity
          • Internal
            • Bias and confounding
          • External
            • Generalizability
        • Diagnostic testing
          • Sensitivity, specificity, positive predictive value, negative predictive value,likelihood ratio
    • MEDICATION / PATIENT SAFETY PRACTICES
      • Policies and procedures to ensure safety and effectiveness of persons, medical productsand pharmacy services
      • Vigilance Program – adverse drug reaction monitoring
      • Health MedEffect: advisories, warnings and recalls
      • Development of strategies and actions to prevent medication incidents
        • Error-prone abbreviations and dosage designations
        • Look-alike and sound-alike drug names
      • Identification, management, and documentation of medication incidentsNationalSystem for Incident Reporting (NSIR) and Canadian Medication Incident Reports andPrevention System (CMIRPS)
      • Institute for Safe Medication Practices (ISMP)
      • Medication reconciliation
      • Patient Safety Institute (PSI)
    • LAW / JURISPRUDENCE
      • Provincial Regulatory Authorities (PRAs)
        • Mandate, Roles, Responsibilities
      • NAPRA
        • Mandate, Roles, Responsibilities
      • Federal legislation
        • Prescriptive authorities and regulatory issues pertaining to the profession ofpharmacy
        • Food and Drugs Act and Regulations
        • Controlled Drugs and Substances Act
          • Precursor Control Regulations
          • Benzodiazepines and other Targeted Substances Regulations
          • Marihuana medical access
        • Narcotic Control Regulations
          • Privacy legislation
          • Personal Information Protection and Electronic Documents Act (PIPEDA)
        • Personal Information Protection and Electronic Documents Act (PIPEDA)
          • Hazardous Products Act
          • WHMIS
    • PROFESSIONALISM/ ETHICS
      • Ethical principles
        • Beneficence, nonmaleficence, autonomy, justice, veracity, fidelity
      • Patient consent and decision-making
        • Capacity, encumbrances, competency
        • Patient surrogates: substituted judgement, best interest judgment, advance
        • directives, living wills, children and minors, the place of the family
      • Respecting professional boundaries
      • Pharmacist conscientious objection (right to refuse)
      • Other Issues in pharmacy and health care ethics
        • Clinical drug trials research
        • Health reform and allocation of limited resources
        • Interdisciplinary decision-making
        • Ethics committees
        • Conflict of interest (gifts from patients and the pharmaceutical industry)
      • Professionalism
        • Trust, integrity, competence, respect, altruism, compassion, collegiality
    • COLLABORATIVE PATIENT CARE
      • Collaboration with other health care professionals to optimize patient outcomes
      • Referral to other health care providers for specific services
        • Identifying need
        • Most appropriate resource or health care professional
      • Effective working relationships
        • Establishing rapport
        • Decision-making strategies
        • Accountability
        • Conflict resolution
        • Scopes of practice
      • Promotion of health and wellness in the community
  • 
  • 
  • BEHAVIOURAL, SOCIAL AND ADMINISTRATIVEPHARMACY SCIENCES
    • Basic Responsibilities of Management